| Entry |
|
|---|
| Name |
Ketophenylbutazone (JAN);
Kebuzone (INN) |
|---|
| Formula |
C19H18N2O3
|
|---|
| Exact mass |
322.1317
|
|---|
| Mol weight |
322.3578
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01947 Anti-inflammatory drug, pyrazolone
DG01949 Anti-inflammatory drug, phenylbutazones
|
|---|
| Remark |
|
|---|
| Efficacy |
Anti-inflammatory |
|---|
| Comment |
Pyrazolone derivative, phenylbutazone type
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AA Butylpyrazolidines
M01AA06 Kebuzone
D01567 Ketophenylbutazone (JAN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01947 Anti-inflammatory drug, pyrazolone
DG01949 Anti-inflammatory drug, phenylbutazones
D01567 Ketophenylbutazone
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 24
1 C1y C 18.0168 -13.2525
2 C1b C 19.4187 -13.2525
3 C5x C 17.1758 -12.1310
4 N1y N 15.8674 -12.5516
5 N1y N 15.8674 -13.9534
6 C5x C 17.1758 -14.3739
7 C8x C 12.2226 -10.4489
8 C8x C 12.2226 -11.8507
9 C8x C 13.4376 -12.5516
10 C8y C 14.6525 -11.8507
11 C8x C 14.6525 -10.4489
12 C8x C 13.4376 -9.7480
13 C8x C 12.2226 -14.6543
14 C8x C 12.2226 -16.0561
15 C8x C 13.4376 -16.7570
16 C8x C 14.6525 -16.0561
17 C8y C 14.6525 -14.6543
18 C8x C 13.4376 -13.9534
19 C1b C 20.1196 -12.0385
20 C5a C 21.5214 -12.0385
21 O5a O 22.2219 -13.2518
22 C1a C 22.2227 -10.8239
23 O5x O 17.6009 -10.7952
24 O5x O 17.6009 -15.7098
BOND 26
1 1 2 1
2 1 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 7 8 2
8 8 9 1
9 9 10 2
10 10 11 1
11 11 12 2
12 7 12 1
13 10 4 1
14 13 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 13 18 1
20 17 5 1
21 2 19 1
22 19 20 1
23 20 21 2
24 20 22 1
25 3 23 2
26 6 24 2
|
|---|
